StockData
Herbalife Ltd. logo

Herbalife Ltd. (HLF) stock

HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$15.57−0.58 (-3.59%)

Close on Nov 17, 2026Market cap $1.63BP/E 10.0Yield –

Herbalife ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Herbalife's ebitda for the twelve months ending Jun 30, 2026 was $613.10M, up 0.5% year over year. For fiscal 2025 it was $602.20M, up 18.7% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $841.70M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$602.20M+18.7%
FY2024Dec 31, 2024$507.30M+8.0%
FY2023Dec 31, 2023$469.70M-28.9%
FY2022Dec 31, 2022$660.60M-21.5%
FY2021Dec 31, 2021$841.70M+13.6%
FY2020Dec 31, 2020$740.90M+11.3%
FY2019Dec 31, 2019$665.80M-15.0%
FY2018Dec 31, 2018$783.50M+9.3%
FY2017Dec 31, 2017$716.90M+28.8%
FY2016Dec 31, 2016$556.40M-18.4%
FY2015Dec 31, 2015$681.60M+12.3%
FY2014Dec 31, 2014$606.70M-26.0%
FY2013Dec 31, 2013$820.00M+11.4%
FY2012Dec 31, 2012$735.80M+16.0%
FY2011Dec 31, 2011$634.12M+39.0%
FY2010Dec 31, 2010$456.13M+27.2%
FY2009Dec 31, 2009$358.47M-5.9%
FY2008Dec 31, 2008$380.98M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$159.70M-2.1%
Q1 FY2026Mar 31, 2026$167.80M+9.3%
Q4 FY2025Dec 31, 2025$129.10M-4.7%
Q3 FY2025Sep 30, 2025$156.50M-0.8%
Q2 FY2025Jun 30, 2025$163.10M+44.3%
Q1 FY2025Mar 31, 2025$153.50M+51.8%
Q4 FY2024Dec 31, 2024$135.50M+61.3%
Q3 FY2024Sep 30, 2024$157.70M+16.7%
Q2 FY2024Jun 30, 2024$113.00M-25.9%
Q1 FY2024Mar 31, 2024$101.10M+3.1%
Q4 FY2023Dec 31, 2023$84.00M-28.3%
Q3 FY2023Sep 30, 2023$135.10M-23.2%
Q2 FY2023Jun 30, 2023$152.50M-17.7%
Q1 FY2023Mar 31, 2023$98.10M-46.2%
Q4 FY2022Dec 31, 2022$117.10M+4.7%
Q3 FY2022Sep 30, 2022$176.00M-18.5%
Q2 FY2022Jun 30, 2022$185.20M-30.1%
Q1 FY2022Mar 31, 2022$182.30M-26.8%
Q4 FY2021Dec 31, 2021$111.80M-35.9%
Q3 FY2021Sep 30, 2021$216.00M-6.6%
Q2 FY2021Jun 30, 2021$265.00M+23.0%
Q1 FY2021Mar 31, 2021$248.90M+107.8%
Q4 FY2020Dec 31, 2020$174.40M+31.4%
Q3 FY2020Sep 30, 2020$231.30M+37.7%
Q2 FY2020Jun 30, 2020$215.40M+21.2%
Q1 FY2020Mar 31, 2020$119.80M-36.1%
Q4 FY2019Dec 31, 2019$132.70M-23.1%
Q3 FY2019Sep 30, 2019$168.00M-20.9%
Q2 FY2019Jun 30, 2019$177.70M-18.1%
Q1 FY2019Mar 31, 2019$187.40M+3.3%
Q4 FY2018Dec 31, 2018$172.60M-1.4%
Q3 FY2018Sep 30, 2018$212.50M+47.1%
Q2 FY2018Jun 30, 2018$217.00M-5.2%
Q1 FY2018Mar 31, 2018$181.40M+7.8%
Q4 FY2017Dec 31, 2017$175.10M-4.8%
Q3 FY2017Sep 30, 2017$144.50M-18.0%
Q2 FY2017Jun 30, 2017$229.00M–
Q1 FY2017Mar 31, 2017$168.30M–
Q4 FY2016Dec 31, 2016$183.90M–
Q3 FY2016Sep 30, 2016$176.20M–

More Herbalife figures

See a number that looks wrong?